Table 1. Baseline Characteristics and Association With LVEF.
*p-value less than 0.05 is considered significant.
| Variable | Total (n = 317) | LVEF < 40% (n = 105) | LVEF 40-49% (n = 142) | LVEF ≥ 50% (n = 70) | p-value | |
| Age (years) | Mean ± SD | 58.3 ± 12.4 | 60.1 ± 12.3 | 57.2 ± 11.8 | 53.5 ± 11.0 | 0.002 |
| Gender | Male | 214 (67.5%) | 76 (72.4%) | 92 (64.8%) | 46 (65.7%) | 0.389 |
| Female | 103 (32.5%) | 29 (27.6%) | 50 (35.2%) | 24 (34.3%) | ||
| Comorbidities | Hypertension | 168 (53.0%) | 60 (57.1%) | 70 (49.3%) | 38 (54.3%) | 0.379 |
| Diabetes Mellitus | 130 (41.0%) | 50 (47.6%) | 56 (39.4%) | 24 (34.3%) | 0.145 | |
| Smoking | 115 (36.3%) | 48 (45.7%) | 40 (28.2%) | 27 (38.6%) | 0.039 | |
| Dyslipidemia | 142 (44.8%) | 48 (45.7%) | 56 (39.4%) | 38 (54.3%) | 0.182 | |
| Time to Presentation (hours) | 4.6 ± 3.2 | 5.2 ± 3.1 | 4.4 ± 3.0 | 3.9 ± 2.9 | 0.018 | |
| Revascularization Therapy | Primary Angioplasty | 145 (45.7%) | 45 (42.9%) | 75 (52.8%) | 25 (35.7%) | 0.042 |
| Thrombolysis | 92 (29.0%) | 35 (33.3%) | 35 (24.6%) | 22 (31.4%) | 0.298 | |
| Spontaneous Recanalization | 80 (25.3%) | 25 (23.8%) | 32 (22.5%) | 23 (32.9%) | 0.211 | |
| Mortality | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | - | |
| Coronary Angiography | 317 (100%) | 105 (100%) | 142 (100%) | 70 (100%) | N/A | |